• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX25 OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX25 OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number N/A
Device Problem Increase in Pressure (1491)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/14/2023
Event Type  Injury  
Event Description
The user facility reported that during on-pump, pressure at the venous blood inlet port on the capiox device increased.There was no problem in the gas exchange performance.The blood flow rate was not sufficient; therefore, the oxygenator was changed out.The procedure was performed swiftly, and the patient was not harmed.There was no patient injury or surgical intervention required.The procedure outcome was not reported.The final patient impact was not harmed.
 
Manufacturer Narrative
Udi: n/a as this product code is not exported to the us market.Implanted date: device was not implanted.Explanted date: device was not explanted.Initial reporter occupation: clinical engineer.Pma/510(k): k130280.The actual device has been returned for evaluation.Visual inspection of the actual sample upon receipt found no breakage in the appearance.Physiological saline solution was flowed by gravity into the actual sample.As a result, formation of blood clots was observed over the oxygenation module entirely.The actual sample was filled with glutaraldehyde-containing saline solution and fixed, and then the housing and the filter was removed.Visual inspection of the oxygenation module found formation of blood clots.There was no anomaly in fiber winding condition.The oxygenation module was inspected visually while the fiber layer was removed gradually.The amount of blood clots was found to be greater the further inside the gas exchange area.There was no anomaly in fiber winding condition.The heat exchanger was separated from the outer cylinder and subjected to visual and magnifying inspection.Blood clots were found sticking all over the heat exchanger.No deformation that could lead to a clogging was observed.Review of the manufacturing record and shipping inspection record of the actual sample found no anomaly in them.A search of the past complaint file found no other similar report with the involved product code/lot number.The investigation result showed formation of blood clots in the actual sample.As for the cause of this event, it was conceivable that blood clots formed due to some factor and clogged the oxygenator, leading to the increasing pressure at the venous blood inlet port.However, it was not possible to clarify the cause of blood clot formation from the condition of the actual sample.Relevant instructions for use (ifu) reference: "do not reduce heparin during circulation.Otherwise, blood clotting might occur.(warnings)." "adequate heparinization of the blood is required to prevent it from clotting in the system.(warnings)." terumo medical products (tmp) (importer) registration no.(b)(4) is submitting this report on behalf of ashitaka factory of terumo corporation (manufacturer) registration no.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX25 OXYGENATOR
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, 418
JA   418
Manufacturer Contact
gina digioia
reg. no. 2243441
950 elkton blvd.
elkton, MD 21921
6402040886
MDR Report Key16362867
MDR Text Key309391192
Report Number9681834-2023-00010
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K071572
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue NumberCX-FX25REV
Device Lot Number220826
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/18/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/16/2023
Initial Date FDA Received02/13/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/26/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-